News

A US study suggests that symptomatic infection with herpes simplex virus type 1 (HSV-1), the virus that causes cold sores, may increase the risk of Alzheimer’s disease. People treated with antiviral drugs had a lower risk.

Research reveals that ketamine stabilizes brain activity in a dose-dependent way. The study used high-density EEG to track changes in brain stability, suggesting ketamine’s effects on brain dynamics might be central to its therapeutic use.

A study shows that ADHD can increase obesity risk through impulsive behaviors and biological pathways. The study highlights how urban environments, including access to mental health services and food insecurity, shape this link.

A new study has revealed genes and cellular pathways that haven’t been linked to Alzheimer’s before, providing new drug targets.

Researchers have developed a new machine learning model that can evaluate a patient's risk of developing postpartum depression based on readily accessible clinical and demographic factors.

A study by Xiaowei Gu and Joshua Johansen at RIKEN identifies neural pathways in the rat brain for learning inferred emotions. Their research shows how the medial prefrontal cortex and amygdala work together to form higher-order emotional responses.

A study from VIB-KU Leuven reveals how the interaction between the proteins GPR158 and PLCXD2 regulates synaptic maturation. This discovery has implications for understanding learning and memory.

An ion channel in the brain's neurons has a "molecular memory", which contributes to the formation and preservation of lifelong memories.

A new discovery provides a unique example of sexual dimorphism in the structure of a single neuron, which is linked to behavioral differences.

Oveporexton is an investigational oral orexin receptor 2-selective agonist designed to restore orexin signaling to address the underlying orexin deficiency that causes narcolepsy. Learn more about the results of the oveporexton Phase 2b trials.